PATENT CLAIM ANALYSIS

Application Number: 16055659
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-08
Patent Classification: ["424", "139100"]

Abstract:
The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind to the Nogo-66 receptor. Specifically, these antibodies have the ability to inhibit the binding of the natural ligand of the Nogo-66 receptor and neutralize the Nogo-66 receptor. These antibodies or portions thereof of the invention are useful for detecting NgR and for inhibiting NgR activity, for example in a human suffering from a disorder in which NgR or Nogo-66 activity is detrimental.

Claim (Index 44):
A method for decreasing Nogo-66 binding to Nogo-66 receptor in a subject in need thereof, comprising the step of administering to the subject an isolated monoclonal anti-Nogo-66 antibody.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.6875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11943770', '14989532', '14013916', '11983775', '12693940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7356096176693065
- 35 USC 102 Novelty (BERT): 0.5590284295306895
- Combined Prediction Score: 0.7179514988554448
- Mean Citation Score: 391.015772
- Max Citation Score: 460.20157
- Similarity Product: 296.691015296703

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test